PULM - Pulmatrix, Inc. Common Stock

Day	1m	10m	60m	PreMarket	Market	AfterHours	Gap
4.99 -0.23 (-4.65%)	---	---	---	---	-0.23 (-4.65%)	---	---

Pulmatrix Inc is a biopharmaceutical company that has focused on the development of novel inhaled therapeutic products intended to prevent and treat migraine and respiratory diseases with important unmet medical needs using its patented dry powder delivery technology, iSPERSE. Its pipeline of clinical assets includes PUR3100 for the treatment of acute migraine, PUR1800 for the treatment of acute exacerbations of chronic obstructive pulmonary disease (AECOPD), and PUR1900 for the treatment of ABPA in patients with asthma and in patients with cystic fibrosis (CF).

Category: PHARMACEUTICAL PREPARATIONS

Market Period: Closed

Earnings & Ratios

Basic EPS:: -0.42
Diluted EPS:: -0.42
Basic P/E:: -11.329
Diluted P/E:: -11.329
RSI(14) 1m:: 46.1
VWAP:: 4.76
RVol:: 0.6778

Events

Period	Kind	Movement	Occurred At
1m	Price increase 1m	4.75 +0.07 (+1.39%)	Oct 15 15:41
1m	Price decrease 1m	4.77 -0.06 (-1.21%)	Oct 15 15:28
1m	Price increase 1m	4.96 +0.05 (+1.02%)	Oct 15 10:40